Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tormod Fladby

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
The Clinical Neuropsychologist|March 9, 2019
Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 yearsBjørn-Eivind Kirsebom, Ragna Espenes, Erik Hessen, et al.
Brain Communications|May 5, 2025
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's diseaseStephanie Knudtzon, Kaja Nordengen, Lene Pålhaugen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2024
Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob diseaseGiuseppe Mario Bentivenga, Fernando Gonzalez-Ortiz, Simone Baiardi, et al.
JAMA Network Open|November 22, 2022
Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau BurdenGøril Rolfseng Grøntvedt, Sigrid Botne Sando, Camilla Lauridsen, et al.
Journal of Parkinson'S Disease|April 11, 2016
Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's DiseasesErik Hessen, Ane Løvli Stav, Eirik Auning, et al.
Nature Communications|March 10, 2026
Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer's diseaseLinbin Dai, Bjørn-Eivind Kirsebom, Chenxi Wang, et al.
Neurobiology of Aging|July 16, 2025
Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomesGrit Richter, Bjørn-Eivind Kirsebom, Jonas Alexander Jarholm, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2020
Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's DiseaseAnne Katrine Bergland, Petroula Proitsi, Bjørn-Eivind Kirsebom, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 25, 2024
Neuronal plasma biomarkers in acute ischemic strokeJulia K Gundersen, Fernando Gonzalez-Ortiz, Thomas Karikari, et al.
Applied Neuropsychology. Adult|February 17, 2025
Norwegian normative data for regression-based D-KEFS color-word interference test derived measures and comparison to conventional contrast measuresIngrid Myrvoll Lorentzen, Jacob Espenes, Ingvild Vøllo Eliassen, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
The Clinical Neuropsychologist|March 9, 2019
Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 yearsBjørn-Eivind Kirsebom, Ragna Espenes, Erik Hessen, et al.
Brain Communications|May 5, 2025
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's diseaseStephanie Knudtzon, Kaja Nordengen, Lene Pålhaugen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2024
Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob diseaseGiuseppe Mario Bentivenga, Fernando Gonzalez-Ortiz, Simone Baiardi, et al.
JAMA Network Open|November 22, 2022
Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau BurdenGøril Rolfseng Grøntvedt, Sigrid Botne Sando, Camilla Lauridsen, et al.
Journal of Parkinson'S Disease|April 11, 2016
Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's DiseasesErik Hessen, Ane Løvli Stav, Eirik Auning, et al.
Nature Communications|March 10, 2026
Cerebrospinal fluid NPTX1 and NPTXR predict neurodegeneration and clinical progression in Alzheimer's diseaseLinbin Dai, Bjørn-Eivind Kirsebom, Chenxi Wang, et al.
Neurobiology of Aging|July 16, 2025
Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomesGrit Richter, Bjørn-Eivind Kirsebom, Jonas Alexander Jarholm, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2020
Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's DiseaseAnne Katrine Bergland, Petroula Proitsi, Bjørn-Eivind Kirsebom, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 25, 2024
Neuronal plasma biomarkers in acute ischemic strokeJulia K Gundersen, Fernando Gonzalez-Ortiz, Thomas Karikari, et al.
Applied Neuropsychology. Adult|February 17, 2025
Norwegian normative data for regression-based D-KEFS color-word interference test derived measures and comparison to conventional contrast measuresIngrid Myrvoll Lorentzen, Jacob Espenes, Ingvild Vøllo Eliassen, et al.
Pageof 17